| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.30B | 99.56B | 88.40B | 79.28B | 83.76B | 68.79B |
| Gross Profit | 65.82B | 76.88B | 70.22B | 63.76B | 74.52B | 67.41B |
| EBITDA | 19.88B | 31.92B | 22.47B | 17.13B | 16.34B | 18.29B |
| Net Income | 13.98B | 18.86B | 13.70B | 9.64B | 9.17B | 11.70B |
Balance Sheet | ||||||
| Total Assets | 5.70T | 5.85T | 5.75T | 5.84T | 5.81T | 5.75T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 919.08B | 861.93B | 1.08T | 1.20T | 1.12T |
| Total Debt | 508.20B | 473.88B | 621.79B | 630.88B | 644.79B | 736.57B |
| Total Liabilities | 5.37T | 5.46T | 5.43T | 5.51T | 5.53T | 5.46T |
| Stockholders Equity | 336.83B | 384.43B | 328.26B | 329.19B | 281.10B | 284.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 25.63B | -715.00M | 0.00 | -154.66B | 0.00 |
| Operating Cash Flow | 0.00 | 28.13B | 1.44B | 0.00 | -152.15B | 0.00 |
| Investing Cash Flow | 0.00 | 6.09B | -162.56B | -16.58B | 227.01B | -29.11B |
| Financing Cash Flow | 0.00 | 9.99B | -67.45B | -33.92B | -3.19B | 105.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥265.63B | 14.34 | ― | 2.53% | 16.63% | 19.98% | |
70 Outperform | ¥277.26B | 11.25 | 7.61% | 3.81% | 17.66% | 24.57% | |
70 Outperform | ¥312.18B | 13.05 | ― | 2.27% | 26.67% | 31.83% | |
69 Neutral | ¥267.90B | 12.97 | ― | 3.46% | 11.64% | 26.63% | |
68 Neutral | ¥273.69B | 15.26 | ― | 2.13% | 15.39% | 26.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥280.93B | 12.58 | ― | 2.55% | 18.30% | 38.04% |